Your browser doesn't support javascript.
loading
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
Lynce, Filipa; Wang, Hongkun; Petricoin, Emanuel F; Pohlmann, Paula R; Smaglo, Brandon; Hwang, Jimmy; He, Aiwu R; Subramaniam, Deepa S; Deeken, John; Marshall, John; Pishvaian, Michael J.
Afiliación
  • Lynce F; Lombardi Comprehensive Cancer Center, 3800 Reservoir Road NW, Washington, DC, 20007, USA.
  • Wang H; Georgetown University Medical Center, Washington, DC, USA.
  • Petricoin EF; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
  • Pohlmann PR; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Smaglo B; Lombardi Comprehensive Cancer Center, 3800 Reservoir Road NW, Washington, DC, 20007, USA.
  • Hwang J; Georgetown University Medical Center, Washington, DC, USA.
  • He AR; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Subramaniam DS; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.
  • Deeken J; Lombardi Comprehensive Cancer Center, 3800 Reservoir Road NW, Washington, DC, 20007, USA.
  • Marshall J; Georgetown University Medical Center, Washington, DC, USA.
  • Pishvaian MJ; Lombardi Comprehensive Cancer Center, 3800 Reservoir Road NW, Washington, DC, 20007, USA.
Cancer Chemother Pharmacol ; 84(5): 1145-1151, 2019 11.
Article en En | MEDLINE | ID: mdl-31538230

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos